Solomon Langermann
Equibles does not estimate personal net worth.
About Solomon Langermann
NextCure, Inc. reported in an 8-K filed August 25, 2025 that Solomon Langermann resigned as Chief Scientific Officer, effective September 1, 2025. The proxy statement of NextCure, Inc. reports total compensation of $882,845 for Solomon Langermann in fiscal 2024, including a base salary of $463,338. Disclosed compensation is on record for 2 fiscal years.
“On August 21, 2025, Solomon Langermann, Ph.D., resigned from his position as Chief Scientific Officer of NextCure, Inc. (the "Company"), effective September 1, 2025.”
Affiliation history
-
NextCure, Inc. (NXTC)
Proxy statement
Start not stated–2025-09-01
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | NextCure, Inc. (NXTC) | Chief Scientific Officer | $463,338 | $882,845 |
| 2023 | NextCure, Inc. (NXTC) | Chief Scientific Officer | $448,238 | $681,586 |